Türkoğlu Cengizhan, Aliyev Farid, Celiker Cengiz, Cetin Gökhan
Department of Cardiology, Division of Pacing and Electrophysiology, Istanbul University, Institute of Cardiology, Istanbul, Turkey.
Turk Kardiyol Dern Ars. 2009 Sep;37(6):403-6.
Monitoring intrathoracic impedance has become an integral part of follow-up of patients with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy/defibrillator due to heart failure. However, several noncardiac factors may influence intrathoracic impedance. We report on an unusual cause of decrease in intrathoracic impedance in a 54-year-old male patient following successful implantation of biventricular ICD for heart failure symptoms due to nonischemic dilated cardiomyopathy and severely impaired left ventricular systolic function. During the follow-up period, the patient presented several times with the OptiVol alarm due to an increase in the OptiVol fluid index, in the absence of symptoms or signs of heart failure. Further inquiry into the possible causes of decreased intrathoracic impedance revealed that the patient had frequent episodes of irritable bowel syndrome, which increased intra-abdominal pressure, leading to elevation of diaphragm and subsequent compression of intrathoracic organs, and thus to a decrease in intrathoracic impedance.
监测胸腔内阻抗已成为植入式心脏复律除颤器(ICD)或因心力衰竭接受心脏再同步治疗/除颤器治疗患者随访的一个组成部分。然而,一些非心脏因素可能会影响胸腔内阻抗。我们报告了一名54岁男性患者胸腔内阻抗降低的不寻常原因,该患者因非缺血性扩张型心肌病和严重受损的左心室收缩功能,成功植入双心室ICD以治疗心力衰竭症状。在随访期间,患者多次因OptiVol液体指数升高出现OptiVol警报,而此时并无心力衰竭的症状或体征。对胸腔内阻抗降低的可能原因进行进一步调查发现,该患者频繁发作肠易激综合征,这增加了腹内压,导致膈肌抬高,进而压迫胸腔内器官,从而使胸腔内阻抗降低。